Navigation Links
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
Date:6/16/2008

Data published in the Journal of the American Society of Hypertension

demonstrate that early blockade of angiotensin II reversed vascular

hypertrophy

PARSIPPANY, N.J., June 16 /PRNewswire/ -- A new study published in the current Journal of the American Society of Hypertension demonstrates that the hypertension treatment olmesartan medoxomil was effective in reversing the narrowing of the arteries that occurs in patients with hypertension. The study, titled VIOS (Vascular Improvement with Olmesartan medoxomil Study) was a one-year, exploratory study that evaluated the effects of an angiotensin receptor blocker (olmesartan medoxomil) vs. a beta-blocker (atenolol) on vascular function and structure in patients with Stage 1 hypertension, independent of the blood pressure lowering effects of these agents.(1)

In the VIOS trial, olmesartan medoxomil, through early blockade of angiotensin II, improved the structure abnormalities of resistance arteries in patients with hypertension as measured by arterial wall to lumen ratio (W/L), returning arterial architecture to normal levels after one year of treatment. This protective effect was not seen with the comparator agent in the study, atenolol.(2) Olmesartan medoxomil is marketed in the United States by Daiichi Sankyo, Inc., as BENICAR(R). BENICAR and BENICAR HCT(R) (olmesartan medoxomil/hydrochlorothiazide) are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. BENICAR HCT is not indicated for initial therapy. BENICAR and BENICAR HCT have not been FDA approved for other indications such as end organ disease or other hypertension related morbidity.

"We believe the VIOS data add to the growing evidence for the role of angiotensin receptor blockers in preventing or reversing vascular damage at many stages during this disease process," said Carlos M. Ferrario, M.D., one of the study's lead inve
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
2. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
3. Pharmaxis Long-Term Safety Study of Bronchitol Completes
4. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
5. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
6. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
7. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
8. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
9. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
10. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
11. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 Boston Scientific Corporation (NYSE: ... J. Dockendorff and Stephen P. MacMillan to ... members of the board, Uwe E. Reinhardt and ... at the company,s annual meeting of stockholders in May 2015. ... the executive vice president and chief financial officer of Covidien ...
(Date:3/3/2015)... Ky. , March 3, 2015 Dr. ... Louisville,s greatest leaders in aesthetics. In addition ... Brownsboro Plastic and Hand Surgery practice, Dr. Cummins now ... Louisville Tattoo Removal clinic . Dr. Cummins performs all ... "I founded Louisville Tattoo Removal in order to ...
(Date:3/3/2015)... /CNW/ - The issue: Health ... at Art Nails Ltd., located at 751 Helmcken St., ... contained no labelling. All products administered by injection in ... have approved labelling. The store owner claimed ... risks associated with injecting an unauthorized version of a health product ...
Breaking Medicine Technology:Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors 2Surgeon Owned And Operated Louisville Tattoo Removal Offers Astanza Duality Laser Treatments 2Advisory - Health product seized from Art Nails in Vancouver 2
... 21, 2007-- Serotonin is a,neurotransmitter that helps ... to determine the role of serotonin in,patients ... 48 females --,including individuals with IBS, individuals ... and healthy volunteers.,Biopsies were obtained from the ...
... MADISON, N.J., May 9 /PRNewswire-FirstCall/ -- Wyeth (NYSE: ... Administration's (FDA),San Juan District Office has informed the ... Puerto Rico manufacturing,facility has resulted in a positive ... that any issues found by the FDA have,either ...
Cached Medicine Technology:FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 2FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 3
(Date:3/3/2015)... Chicago, Il. (PRWEB) March 03, 2015 ... – is set to reveal the world’s first fully ... you are breathing and controls an air purifier to ... the user informed, and in control, via phone, tablet ... air purifiers in over 50 countries worldwide, will unveil ...
(Date:3/3/2015)... VA (PRWEB) March 03, 2015 Today ... the Portland-based maker of bike, skate, snow, water, and ... awareness about brain injury. The partnership kicks off with ... website at http://www.nutcasehelmets.com to BIAA during the ... Month. , Each year BIAA leads the nation in ...
(Date:3/3/2015)... 2015 The report “Alopecia – Pipeline ... development for Alopecia. Alopecia is the loss of hair. ... types of alopecia. Causes for alopecia include aging, genetics, ... may include male pattern hair loss, female diffuse hair ... be classified as focal or diffuse and by the ...
(Date:3/3/2015)... March 03, 2015 While it is ... primary reason why young Canadian drivers are signing up ... greater value proposition to be enticed. Due to current ... a very stripped-back form. Its full capability is ... where tracking, predictive maintenance, emergency breakdown services are at ...
(Date:3/3/2015)... Topical BioMedics, Inc., announces its March Pain Management Workshop will ... 10th, 12pm – 1pm and 4pm to 5pm. Afterward, ... , The Pain Management Workshops are free and open ... is “Opioid Addiction: An Over-Medicated Society.” It’s a ... the world’s population, yet consumers 99% of the world’s Vicodin ...
Breaking Medicine News(10 mins):Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5
... Diabetes Will Meet Nick Jonas in Los Angeles and,Become ... N.Y., Oct. 30 To kick off Diabetes Awareness,Month, ... have,won the opportunity to meet teen pop sensation Nick ... In Nick,s Shoes" (W.I.N.S.),sweepstakes. These Grand Prize winners will ...
... last Sunday in March increases the risk of myocardial infarction ... in the autumn reduces the risk, albeit to a lesser ... the prestigious New England Journal of Medicine . , ... myocardial infarction in Sweden has changed with the summer and ...
... off American,Diabetes Month this November, the American Diabetes ... along with Eli,Lilly and Company,s national educational initiative, ... Update, an educational program for people affected by ... November 1, at the Greater,Grace Temple, 23500 W. ...
... Resource for Sharing Product, Educational Expertise,with ASCs, ... Braun Medical Inc. (B.,Braun) has launched a ... educational and editorial information for ambulatory surgical ... The new online resource, http://www.asc.bbraunusa.com, ...
... First Company to Reach Pivotal Study for Spine Nucleus ... Technology,Inc. announced today, the U.S. Food and Drug Administration ... the NuBac(R) Nucleus,Replacement Device for the spine., Pioneer,s ... MD, MBA,says, "This is a huge milestone and accomplishment ...
... Therapeutics,Inc. (OTC Bulletin Board: ARNI.OB), a clinical-stage biopharmaceutical,company ... William F. Hamilton, Ph.D. to its Board of ... Hamilton has over 40 years experience as a,professor ... the areas of,technology strategy and planning, entrepreneurship and ...
Cached Medicine News:Health News:Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners 2Health News:Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners 3Health News:Clock-shifts affect risk of heart attack 2Health News:American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes 2Health News:American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes 3Health News:B. Braun Medical Inc. Launches Ambulatory Surgical Center Website 2Health News:Pioneer(R) Surgical Technology's NuBac(R) Nucleus Replacement Device Wins FDA Approval for IDE Pivotal Study 2Health News:Pioneer(R) Surgical Technology's NuBac(R) Nucleus Replacement Device Wins FDA Approval for IDE Pivotal Study 3Health News:Arno Therapeutics Appoints William F. Hamilton to Board of Directors 2Health News:Arno Therapeutics Appoints William F. Hamilton to Board of Directors 3
... patented Orion incorporates superior optics in a ... The fully adjustable headband, made of white ... on the brow, directing the spot along ... on the headband position the cable diagonally ...
... Bring the clarity of daylight into the ... Light Source. Designed for a variety of ... instruments, and video equipment - this light ... 300 watts (6,000o K) for superb tissue ...
CO 2 SMO-Capnograph/Pulse Oximeter...
... for an emergency situation, bedside monitoring or ... / Pulse Oximeter delivers accurate SpO 2 ... handheld monitor now contains Nellcors latest OxiMax ... OxiMax sensors. The NPB-75 monitor also features ...
Medicine Products: